Search - tctmd.com

Displaying 1 - 20 of 310

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

Frail Patients Stand to Gain Most From Cardiac Rehab

Michael O'Riordan

November 26, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

L.A. McKeown

November 24, 2025

News Daily News

CMS Greenlights Reimbursement for Renal Denervation Systems

L.A. McKeown

October 29, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Features

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

Michael O'Riordan

September 17, 2025

News Daily News

US Stroke Rehab System Not Serving Patient Needs, Societies Say

L.A. McKeown

August 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

Caitlin E. Cox

July 31, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

News Daily News

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

L.A. McKeown

July 22, 2025

News Conference News SCCT 2025

AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry

Yael L. Maxwell

July 21, 2025

News Daily News

CMS Issues Proposed Coverage Decision for Renal Denervation

Todd Neale

July 11, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

Shelley Wood

February 28, 2025

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Frail Patients Stand to Gain Most From Cardiac Rehab

November 2025 Dispatch for the CV Team

CMS Greenlights Reimbursement for Renal Denervation Systems

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

‘Buzz and Discussion’ Driving Return to In-Person Cardiology Meetings

US Stroke Rehab System Not Serving Patient Needs, Societies Say

TCTMD’s Top 10 Most Popular Stories for July 2025

Heart Disease Treatment Costs $100 Billion per Year in the US

Some Ups, Some Downs in Proposed CMS Reimbursement for 2026, Cardiologists Say

AI-Based Coronary Plaque Analysis Can Inform Management Beyond CCTA: DECIDE Registry

CMS Issues Proposed Coverage Decision for Renal Denervation

TCTMD’s Top 10 Most Popular Stories for June 2025

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

TCTMD’s Top 10 Most Popular Stories for February 2025

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content